Intrinsic Value of S&P & Nasdaq Contact Us

CareTrust REIT, Inc. CTRE NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
79/100
5/7 Pass
SharesGrow Intrinsic Value
$17.53
-55.4%
Analyst Price Target
$42.50
+8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

CareTrust REIT, Inc. (CTRE) trades at a trailing P/E of 26.9, forward P/E of 26.4. Trailing earnings yield is 3.72%, forward earnings yield 3.78%. PEG 0.28 (Peter Lynch undervalued ≤1.0). Graham Number is $24.29.

Criteria proven by this page:

  • VALUE (41/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 26.4 (down from trailing 26.9) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.28 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 3.72% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 3.78% as earnings recover.
  • Analyst consensus target $42.50 (+8% upside) — modest upside expected.

Overall SharesGrow Score: 79/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
79/100
SG Score
View full scorecard →
~
VALUE
41/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
55/100
→ Income
GROWTH
100/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — CTRE

Valuation Multiples
P/E (TTM)26.9
Forward P/E26.4
PEG Ratio0.28
Forward PEG6.15
P/B Ratio2.14
P/S Ratio21.76
EV/EBITDA20.2
Per Share Data
EPS (TTM)$1.44
Forward EPS (Est.)$1.49
Book Value / Share$18.22
Revenue / Share$1.78
FCF / Share$1.70
Yields & Fair Value
Earnings Yield3.72%
Forward Earnings Yield3.78%
Dividend Yield3.60%
Graham Number$24.29
SharesGrow IV$17.53 (-55.4%)
Analyst Target$42.50 (+8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 29.2 0.32 1.90 8.26 4.34%
2017 47.1 -1.53 2.05 9.29 4.32%
2018 25.3 0.25 1.91 9.43 4.30%
2019 41.4 -0.57 2.07 12.07 4.20%
2020 26.1 0.13 2.31 12.02 4.41%
2021 30.5 -1.83 2.39 11.53 4.60%
2022 -239.4 19.95 2.12 9.58 5.91%
2023 44.1 3.24 1.67 11.94 4.87%
2024 33.5 0.54 1.44 18.34 4.11%
2025 23.0 0.24 1.82 15.45 3.52%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.52 $103.94M $29.35M 28.2%
2017 $0.36 $131.12M $25.87M 19.7%
2018 $0.73 $155.38M $57.92M 37.3%
2019 $0.20 $159.06M $18.23M 11.5%
2020 $0.60 $175.69M $57.21M 32.6%
2021 $0.50 $190.2M $48.31M 25.4%
2022 $0.44 $187.51M $42.87M 22.9%
2023 $0.50 $217.77M $53.74M 24.7%
2024 $0.80 $228.26M $125.08M 54.8%
2025 $1.57 $476.59M $320.54M 67.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.48 $1.46 – $1.49 $483.89M $424.28M – $529.64M 5
2027 $1.59 $1.58 – $1.60 $551.3M $483.39M – $603.42M 5
2028 $1.67 $1.58 – $1.79 $687.7M $602.99M – $752.72M 4
2029 $1.69 $1.42 – $1.90 $785.1M $688.39M – $859.34M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message